Retail sale of pharmaceutical products
APOMED AS
Revenue 2024
NOK 15.2m
Operating profit
NOK −20.3m
Equity
NOK −15.2m
Incorporated
2020
Employees
10
Share capital
NOK 1.0m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 15.2m | |
| Total operating costs | 35.5m | |
| Operating profit (EBIT) | −20.3m | |
| Net financial items | −530k | |
| Profit for the year | −20.9m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 4.6m | |
| of which current assets | 1.9m | |
| Equity | −15.2m | |
| Total liabilities | 19.9m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.